New hope for lymphoma patients as experimental drug enters human testing

NCT ID NCT07082803

Summary

This early-stage trial is testing a new drug called TLN-121 for people with non-Hodgkin lymphoma that has come back or hasn't responded to previous treatments. The main goals are to find a safe dose and see how the body processes the drug, both when given alone and when combined with another lymphoma therapy. Researchers will also look for early signs that the drug can shrink tumors in these difficult-to-treat cancers.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • BC Cancer - Vancouver

    RECRUITING

    Vancouver, British Columbia, V5Z 4E6, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Cabrini Health

    RECRUITING

    Malvern, Victoria, 3144, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Linear Clinical Research

    RECRUITING

    Perth, Western Australia, 6009, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Macquarie University Hospital

    RECRUITING

    Macquarie Park, New South Wales, 2113, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Peter MacCallum Cancer Centre

    RECRUITING

    Melbourne, Victoria, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Princess Alexandra Hospital

    RECRUITING

    Woolloongabba, Queensland, 4102, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • SCRI Oncology Partners

    RECRUITING

    Nashville, Tennessee, 37203, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Stanford Medicine Cancer Center

    RECRUITING

    Palo Alto, California, 94304, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The START Center for Cancer Care - Midwest

    RECRUITING

    Grand Rapids, Michigan, 49546, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The University of Texas MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Washington University School of Medicine

    RECRUITING

    St Louis, Missouri, 63108, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.